Clinical Trials Logo

Clinical Trial Summary

The high price of electrocardiograph (ECG) devices - with most hospital-grade devices costing thousands of dollars - is one of the barriers to access of this vital technology. There is a shortage of ECG devices in underserved areas and the devices available on the market currently are not adequate to solve this problem. Our solution is a low-cost high-quality open-access ECG device. This study intends to validate the study ECG device in human patients by demonstrating equivalence between the study ECG device and a gold standard device.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04209062
Study type Interventional
Source Lawson Health Research Institute
Contact Tarek Loubani, MD
Phone 15196858500
Email tarek@tarek.org
Status Not yet recruiting
Phase N/A
Start date January 1, 2023
Completion date July 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT04350008 - BIO|CONCEPT.Renamic Neo Study